From controversy to clarity: reimagining the role of CDK4/6 inhibitors in the adjuvant setting– a number needed to treat perspective
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-06-01
|
| Series: | Journal of Cancer Research and Clinical Oncology |
| Online Access: | https://doi.org/10.1007/s00432-025-06229-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849333887187025920 |
|---|---|
| author | Armando Orlandi |
| author_facet | Armando Orlandi |
| author_sort | Armando Orlandi |
| collection | DOAJ |
| format | Article |
| id | doaj-art-cbd9a458b33b48749ee7e2721fc5f339 |
| institution | Kabale University |
| issn | 1432-1335 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Springer |
| record_format | Article |
| series | Journal of Cancer Research and Clinical Oncology |
| spelling | doaj-art-cbd9a458b33b48749ee7e2721fc5f3392025-08-20T03:45:44ZengSpringerJournal of Cancer Research and Clinical Oncology1432-13352025-06-0115161210.1007/s00432-025-06229-3From controversy to clarity: reimagining the role of CDK4/6 inhibitors in the adjuvant setting– a number needed to treat perspectiveArmando Orlandi0Comprehensive Cancer Center, UOC Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCShttps://doi.org/10.1007/s00432-025-06229-3 |
| spellingShingle | Armando Orlandi From controversy to clarity: reimagining the role of CDK4/6 inhibitors in the adjuvant setting– a number needed to treat perspective Journal of Cancer Research and Clinical Oncology |
| title | From controversy to clarity: reimagining the role of CDK4/6 inhibitors in the adjuvant setting– a number needed to treat perspective |
| title_full | From controversy to clarity: reimagining the role of CDK4/6 inhibitors in the adjuvant setting– a number needed to treat perspective |
| title_fullStr | From controversy to clarity: reimagining the role of CDK4/6 inhibitors in the adjuvant setting– a number needed to treat perspective |
| title_full_unstemmed | From controversy to clarity: reimagining the role of CDK4/6 inhibitors in the adjuvant setting– a number needed to treat perspective |
| title_short | From controversy to clarity: reimagining the role of CDK4/6 inhibitors in the adjuvant setting– a number needed to treat perspective |
| title_sort | from controversy to clarity reimagining the role of cdk4 6 inhibitors in the adjuvant setting a number needed to treat perspective |
| url | https://doi.org/10.1007/s00432-025-06229-3 |
| work_keys_str_mv | AT armandoorlandi fromcontroversytoclarityreimaginingtheroleofcdk46inhibitorsintheadjuvantsettinganumberneededtotreatperspective |